These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
577 related items for PubMed ID: 29559004
1. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Goossens J, Bjerke M, Van Mossevelde S, Van den Bossche T, Goeman J, De Vil B, Sieben A, Martin JJ, Cras P, De Deyn PP, Van Broeckhoven C, van der Zee J, Engelborghs S. Alzheimers Res Ther; 2018 Mar 20; 10(1):31. PubMed ID: 29559004 [Abstract] [Full Text] [Related]
2. Cerebrospinal fluid biomarkers in Progranulin mutations carriers. Carecchio M, Fenoglio C, Cortini F, Comi C, Benussi L, Ghidoni R, Borroni B, De Riz M, Serpente M, Cantoni C, Franceschi M, Albertini V, Monaco F, Rainero I, Binetti G, Padovani A, Bresolin N, Scarpini E, Galimberti D. J Alzheimers Dis; 2011 Mar 20; 27(4):781-90. PubMed ID: 21891865 [Abstract] [Full Text] [Related]
3. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype. Woollacott IOC, Nicholas JM, Heller C, Foiani MS, Moore KM, Russell LL, Paterson RW, Keshavan A, Schott JM, Warren JD, Heslegrave A, Zetterberg H, Rohrer JD. Dement Geriatr Cogn Disord; 2020 Mar 20; 49(1):56-76. PubMed ID: 32344399 [Abstract] [Full Text] [Related]
4. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. Lleó A, Irwin DJ, Illán-Gala I, McMillan CT, Wolk DA, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M. JAMA Neurol; 2018 Jun 01; 75(6):738-745. PubMed ID: 29554190 [Abstract] [Full Text] [Related]
5. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. Abu-Rumeileh S, Mometto N, Bartoletti-Stella A, Polischi B, Oppi F, Poda R, Stanzani-Maserati M, Cortelli P, Liguori R, Capellari S, Parchi P. J Alzheimers Dis; 2018 Jun 01; 66(2):551-563. PubMed ID: 30320576 [Abstract] [Full Text] [Related]
6. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Hu WT, Watts K, Grossman M, Glass J, Lah JJ, Hales C, Shelnutt M, Van Deerlin V, Trojanowski JQ, Levey AI. Neurology; 2013 Nov 26; 81(22):1945-52. PubMed ID: 24174584 [Abstract] [Full Text] [Related]
12. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW. Acta Neuropathol; 2013 Feb 26; 125(2):289-302. PubMed ID: 23053135 [Abstract] [Full Text] [Related]
13. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease. Baldeiras I, Santana I, Leitão MJ, Ribeiro MH, Pascoal R, Duro D, Lemos R, Santiago B, Almeida MR, Oliveira CR. J Neurol Sci; 2015 Nov 15; 358(1-2):308-16. PubMed ID: 26388316 [Abstract] [Full Text] [Related]
14. Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study. Laton J, Van Schependom J, Goossens J, Wiels W, Sieben A, De Deyn PP, Goeman J, Streffer J, van der Zee J, Martin JJ, Van Broeckhoven C, De Vos M, Bjerke M, Nagels G, Engelborghs S. J Alzheimers Dis; 2022 Nov 15; 90(4):1739-1747. PubMed ID: 36336933 [Abstract] [Full Text] [Related]